Home›Stock Screener›Arunjyothi Bio Ventures›Financial Statements

Arunjyothi Bio Ventures Complete Financial Statements

13 Years of Data
2026 - 2010

In FY2010, Arunjyothi Bio Ventures (ABVL) reported revenue ₹0 Cr, net profit ₹0 Cr and EPS ₹0.00. Full financial statements from FY2010 to FY2026 (13 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV.

Complete Financial Data Export

Profitability Ratios

Operating Margin 38.00% 2010 data

Balance Sheet Ratios

Current Ratio 0.50 2010 data
Equity Ratio 53.70% 2010 data

ABVL Revenue, Net Profit & EBITDA — Year-on-Year Growth

ABVL YoY (Dec 2010 vs Sept 2010). For live price, earnings ratios and company overview, see Arunjyothi Bio Ventures stock price NSE.

Assets Growth
-11.5%
Year-over-Year
Equity Growth
-12.1%
Year-over-Year
Operating Cash Flow Growth
+400.0%
Year-over-Year
Investing Cash Flow Growth
+16.7%
Year-over-Year
Financing Cash Flow Growth
-220.0%
Year-over-Year

ABVL Income Statement — Revenue, EBITDA & Net Profit

Arunjyothi Bio Ventures revenue ₹0 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.00 (2010). Compare with Arunjyothi Bio Ventures valuation methods to assess whether the stock is under or overvalued.

Periods ₹ Crores
Particulars Sept 2010 Dec 2010
Revenue 0 0
Expenses 0 0
EBITDA 0 0
Operating Profit Margin % 38.00% 31.00%
Depreciation 0 0
Interest 0 0
Profit Before Tax 0 0
Tax 0 0
Net Profit 0 0
Earnings Per Share (₹) 0.00 0.19

ABVL Balance Sheet — Assets, Liabilities & Shareholders' Equity

ABVL total assets ₹54 Cr, total equity ₹29 Cr, total liabilities ₹ Cr (2026).

Years Annual Data ₹ Crores
Particulars 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
ASSETS
Total Assets 54 61 54 36 2 5 6 6 10 20 2 2
Current Assets 6 16 11 6 1 3 4 4 9 18 0 0
Fixed Assets 46 44 41 0 0 0 0 0 0 0 0 0
Capital Work in Progress 0 0 0 19 0 0 0 0 0 0 0 0
Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Assets 9 18 14 17 2 5 6 6 10 20 2 2
LIABILITIES
Total Liabilities
Current Liabilities 12 16 47 32 0 0 0 0 0 0 0 0
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 29 33 2 2 2 2 2 2 2 2 2 2
Share Capital 19 19 2 2 2 2 2 2 2 2 2 2
Reserves & Surplus 10 15 0 0 0 0 0 0 0 0 0 0

ABVL Cash Flow Statement — Operating, Investing & Financing

Arunjyothi Bio Ventures operating cash flow ₹10 Cr, investing ₹-5 Cr, financing ₹-6 Cr, net cash flow ₹-1 Cr (2026).

Periods ₹ Crores
Particulars March 2026 March 2025 March 2024 March 2023 March 2022 March 2021 March 2020 March 2019 March 2018 March 2017 March 2016 March 2015
Operating Activities 10 2 6 -13 -1 0 1 -3 3 0 0 0
Investing Activities -5 -6 -23 -19 0 0 0 0 0 0 0 0
Financing Activities -6 5 16 32 0 0 0 0 0 0 0 0
Net Cash Flow -1 1 0 0 -1 0 1 -3 3 0 0 0